Precision Cancer Treatment Breakthrough

This is a news story, published by MSN, that relates primarily to Evans news.

Evans news

For more Evans news, you can click here:

more Evans news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

MSN news

For more news from MSN, you can click here:

more news from MSN

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

cancer therapy

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cancer treatment news, radioactive antibody therapy news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

specific radiation therapies

Study Finds

•

Health

Revolutionary cancer drug could remove side-effects from radiation treatments

Summary

Nutrition label

82% Informative

A new cancer treatment could destroy tumors while leaving healthy tissue untouched.

Traditional radiation therapy is like using a sledgehammer to kill a fly — effective but destructive.

University of California-San Francisco researchers developed a microscopic missile system that could change everything.

The breakthrough comes from an ingenious combination of three key components: a drug, a targeting antibody, and a radioactive payload.

It also provides a strategy to overcome drug resistance, a common challenge in cancer therapy.

However, further testing is needed in clinical trials to confirm its safety and efficacy in humans.

The authors disclosed potential conflicts of interest: Craik , Evans , and Rohweder are inventors on a patent application covering part of this work, which is owned by UCSF .

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful